ClinicalTrials.gg
Drug

Vortioxetine clinical trials

Also written Brintellix, Lu AA21004, Trintellix and LuAA21004.

studies test it
98
open now
9
in phase 3
45
first study started
2006

How each study uses Vortioxetine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Vortioxetine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Sept 2013 · TRINTELLIX · NDA 204447 (FDA, Drugs@FDA)
European Union
18 Dec 2013 · Brintellix · EMEA/H/C/002717 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Vortioxetine
65
Vortioxetine (Lu AA21004)
13
Vortioxetine 10 mg
4
Vortioxetine 20Mg Tab
2
Vortioxetine 10 mg/day
2

Brand

Trintellix
15

Development codes

Lu AA21004
30
LuAA21004
3

Other names

Brintellix
50

Studies by the year they started

98 studies that test it; most in 2016 (16)

Studies that test Vortioxetine, by start year
YearStudies
20061
20072
200811
20091
20106
20116
20126
20147
20156
201616
20173
20184
20198
20206
20212
20224
20232
20241
20254
20262

Who runs them

Industry 62 · Other 36

H. Lundbeck A/S (34) · Takeda (25) · Washington University School of Medicine (2) · Brain and Cognition Discovery Foundation (2) · University of Miami (2) · Massachusetts General Hospital (2) · Johns Hopkins University (2) · Northwell Health (1)

Often tested with

Tested in the same studies.

Sertraline (2) · Dasatinib (1) · Quercetin (1) · SSRIs (1) · Cariprazine (1) · Fluoxetine (1) · Duloxetine (1) · Aripiprazole (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Vortioxetine is the comparator. A study of two new drugs counts under both.

  • 1KH607 · Chengdu Kanghong Pharmaceutical Group Co., Ltd. · next primary completion Dec 2027
Reaching primary completion within a year · 2

Studies that test Vortioxetine.

Studies

Open first, then newest update. How each study uses Vortioxetine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 98

See all 98 studies that test Vortioxetine →

As the comparator · 2 — what is tested is compared with Vortioxetine

Codes

What other systems call Vortioxetine · ClinicalTrials.gg INT006835

  • MeSH (NLM) D000078784VortioxetineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 3O2K1S3WQVVORTIOXETINEConfirmed FDA, NLM, Wikidata
  • RxNorm 1455099Confirmed FDA, Wikidata
  • Wikidata Q3563148vortioxetineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152917VortioxetineOne source FDA
  • DrugBank DB09068One source Wikidata

Also registered as vortioxetine hydrobromide (UNII TKS641KOAY · RxNorm 1439834).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.